The new warnings about the GI drug Propulsid (cisapride)
The new warnings about the GI drug Propulsid (cisapride) arecausing many physicians to switch to safer alternatives.
Lots of patients take Propulsid...over $1 billion is sold per year.
But it's causing serious arrhythmias and even somedeaths...especially in patients with predisposing factors, or oninteracting drugs.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber's Letter includes:
- 12 issues every year, with brief articles about new meds and guidelines
- 48+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote